JPMorgan Chase & Co. Acquires 5.2% Stake in LB Pharmaceuticals Inc (LBRX)

On July 16, 2026, JPMorgan Chase & Co. filed a Schedule 13G with the SEC, disclosing a new ownership stake in LB Pharmaceuticals Inc (LBRX). As of the event date on June 30, 2026, the financial institution reported beneficial ownership of 1,497,293 shares of Common Stock, representing 5.2% of the company's outstanding shares. This filing marks an increase from a previous ownership level of 0.0%. The shares are held by JPMorgan Chase & Co. in its capacity as a parent holding company, with subsidiaries JPMorgan Chase Bank, National Association, and J.P. Morgan Investment Management Inc. identified as the relevant entities managing the position. According to the filing, JPMorgan Chase & Co. holds sole voting power over 1,379,375 shares and sole dispositive power over the full 1,497,293 shares. The securities were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer.